(Q34633869)

English

3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

3 August 2017

3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy (English)

1 reference

stated in

Europe PubMed Central

3 August 2017

1 reference

chronic liver disease

0 references

author name string

Maria Tzefos

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed ID

22108148

retrieved

3 August 2017

Jacqueline L Olin

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

22108148

retrieved

3 August 2017

language of work or name

English

0 references

publication date

28 June 2011

1 reference

stated in

Europe PubMed Central

3 August 2017

Journal of Clinical Lipidology

1 reference

stated in

Europe PubMed Central

3 August 2017

5

1 reference

stated in

Europe PubMed Central

3 August 2017

6

1 reference

stated in

Europe PubMed Central

3 August 2017

450-459

1 reference

stated in

Europe PubMed Central

PubMed ID

22108148

retrieved

3 August 2017

Identifiers

DOI

10.1016/J.JACL.2011.06.013

1 reference

stated in

Europe PubMed Central

3 August 2017

1 reference

Europe PubMed Central

PubMed ID

22108148

retrieved

3 August 2017

(Q34633869)

3-hydroxyl-3-methylglutaryl coenzyme A reductase inhibitor use in chronic liver disease: a therapeutic controversy

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)